Finnrick, an independent testing programme, publishes 39 assays for Andy Peps Studio: 36 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 3 did not. Most recent assay 4 Aug 2026.
Andy Peps Studio operates from China, listed by Finnrick as "Trading", has no storefront on record — Finnrick lists only a messaging or social contact. Source: Finnrick, https://www.finnrick.com/vendors/andy-peps-studio.
Andy Peps Studio is listed as active.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 16 | 16 passed, 0 failed |
| Retatrutide | 12 | 11 passed, 1 failed |
| BPC-157 | 6 | 5 passed, 1 failed |
| Tesamorelin | 5 | 4 passed, 1 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from Andy Peps Studio's own website on 2026-08-10. Pages consulted:
Andy Peps Studio is listed as active and we hold 39 Finnrick assays (36 passing, 3 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 39 assays for Andy Peps Studio: 36 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 3 did not. Most recent assay 4 Aug 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Anglo Peptides Review, Anlv Biotechnology Peptides Review, Antiet peptides Review.